Gentian Diagnostics ASA — Director's Dealing 2021

Nov 30, 2021

Notification and public disclosure of transactions by Primary Insiders and their Close Associates

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Njaal Kind
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification/	Initial notification
	Amendment
3	Details of the issuer
a)	Name	Gentian Diagnostics ASA
b)	LEI	5967007LIEEXZXHNM861
4	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
a)	Description of the financial instrument, type of instrument	Share options. The exercise price for the options is NOK 72.60. The right to exercise the options is vested over a period of 3 years, with 1/3 of the options vesting by the end of each year as follows: (i) 1/3 of the options granted, no earlier than 2 years after the allocation date (ii) 1/3 of the options granted, no earlier than 3 years after the allocation date (iii) 1/3 of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees.
	Identification code	N/A
b)	Nature of the transaction	Allocation of options
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		0	40,674
d)	Aggregated information
	- Aggregated volume	40,674
	- Price	0
e)	Date of the transaction	2021-11-30, 10:45 CET
f)	Place of the transaction	XOFF - Outside of trading venue

5	Details of the person discharging managerial responsibilities/person closely associated
b)	Name	Erling Sundrehagen
6	Reason for the notification
c)	Position/status	Chief Scientific Officer
d)	Initial notification/	Initial notification
	Amendment
7	Details of the issuer
c)	Name	Gentian Diagnostics ASA
d)	LEI	5967007LIEEXZXHNM861
8	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
g)	Description of the financial instrument, type of instrument Identification code	Share options. The exercise price for the options is NOK 72.60. The right to exercise the options is vested over a period of 3 years, with 1/3 of the options vesting by the end of each year as follows: (i) 1/3 of the options granted, no earlier than 2 years after the allocation date (ii) 1/3 of the options granted, no earlier than 3 years after the allocation date (iii) 1/3 of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees. N/A
h)	Nature of the transaction	Allocation of options
i)	Price(s) and volume(s)
		Price(s)	Volume(s)
		0	20,000
j)	Aggregated information
	- Aggregated volume	20,000
	- Price	0
k)	Date of the transaction	2021-11-30, 10:45 CET
l)	Place of the transaction	XOFF - Outside of trading venue

9	Details of the person discharging managerial responsibilities/person closely associated
c)	Name	Torsten Knüttel
10	Reason for the notification
e)	Position/status	Vice President R&D
f)	Initial notification/	Initial notification
	Amendment
11	Details of the issuer
e)	Name	Gentian Diagnostics ASA
f)	LEI	5967007LIEEXZXHNM861
12	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
m)	Description of the financial instrument, type of instrument Identification code	Share options. The exercise price for the options is NOK 72.60. The right to exercise the options is vested over a period of 3 years, with 1/3 of the options vesting by the end of each year as follows: (i) 1/3 of the options granted, no earlier than 2 years after the allocation date (ii) 1/3 of the options granted, no earlier than 3 years after the allocation date (iii) 1/3 of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees. N/A
n)	Nature of the transaction	Allocation of options
o)	Price(s) and volume(s)	Price(s) 0	Volume(s) 20,000
p)	Aggregated information
	- Aggregated volume	20,000
	- Price	0
q)	Date of the transaction	2021-11-30, 10:45 CET
r)	Place of the transaction	XOFF - Outside of trading venue

13	Details of the person discharging managerial responsibilities/person closely associated
d)	Name	Jack Andreassen
14	Reason for the notification
g)	Position/status	Vice President Business Development
h)	Initial notification/	Initial notification
	Amendment
15	Details of the issuer
g)	Name	Gentian Diagnostics ASA
h)	LEI	5967007LIEEXZXHNM861
16	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
s)	Description of the financial instrument, type of instrument Identification code	Share options. The exercise price for the options is NOK 72.60. The right to exercise the options is vested over a period of 3 years, with 1/3 of the options vesting by the end of each year as follows: (i) 1/3 of the options granted, no earlier than 2 years after the allocation date (ii) 1/3 of the options granted, no earlier than 3 years after the allocation date (iii) 1/3 of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees. N/A
t)	Nature of the transaction	Allocation of options
u)	Price(s) and volume(s)
		Price(s)	Volume(s)
		0	2,500
v)	Aggregated information
	- Aggregated volume	2,500
	- Price	0
w)	Date of the transaction	2021-11-30, 10:45 CET
x)	Place of the transaction	XOFF - Outside of trading venue

17	Details of the person discharging managerial responsibilities/person closely associated
e)	Name	Markus Jaquemar
18	Reason for the notification
i)	Position/status	Vice President Sales and Marketing
j)	Initial notification/	Initial notification
	Amendment
19	Details of the issuer
i)	Name	Gentian Diagnostics ASA
j)	LEI	5967007LIEEXZXHNM861
20	conducted	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been
y)	Description of the financial instrument, type of instrument Identification code	Share options. The exercise price for the options is NOK 72.60. The right to exercise the options is vested over a period of 3 years, with 1/3 of the options vesting by the end of each year as follows: (i) 1/3 of the options granted, no earlier than 2 years after the allocation date (ii) 1/3 of the options granted, no earlier than 3 years after the allocation date (iii) 1/3 of the options granted, no earlier than 4 years after the allocation date. The options are granted as part of the company's existing option program for key employees. N/A
z)	Nature of the transaction	Allocation of options
aa)	Price(s) and volume(s)	Price(s) 0	Volume(s) 2,500
bb)	Aggregated information
	- Aggregated volume	2,500
	- Price	0
cc)	Date of the transaction	2021-11-30, 10:45 CET
dd)	Place of the transaction	XOFF - Outside of trading venue